Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Interest & Investment Income (2022 - 2025)

Maravai Lifesciences Holdings has reported Interest & Investment Income over the past 4 years, most recently at $2.4 million for Q4 2025.

  • Quarterly results put Interest & Investment Income at $2.4 million for Q4 2025, down 60.5% from a year ago — trailing twelve months through Dec 2025 was $11.4 million (down 58.27% YoY), and the annual figure for FY2025 was $11.4 million, down 58.27%.
  • Interest & Investment Income for Q4 2025 was $2.4 million at Maravai Lifesciences Holdings, down from $2.8 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for MRVI hit a ceiling of $7.5 million in Q4 2023 and a floor of $2.3 million in Q4 2022.
  • Median Interest & Investment Income over the past 4 years was $6.0 million (2023), compared with a mean of $5.3 million.
  • Biggest five-year swings in Interest & Investment Income: skyrocketed 219.03% in 2023 and later plummeted 60.5% in 2025.
  • Maravai Lifesciences Holdings' Interest & Investment Income stood at $2.3 million in 2022, then skyrocketed by 219.03% to $7.5 million in 2023, then dropped by 19.08% to $6.0 million in 2024, then crashed by 60.5% to $2.4 million in 2025.
  • The last three reported values for Interest & Investment Income were $2.4 million (Q4 2025), $2.8 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.